Logo-npj

Read This Article

Article History

Submitted: 23 Apr 2023
Accepted: 01 Jun 2023
ePublished: 04 Jun 2023

  Google Scholar Profile

PubMed Profile

Share This Article!

Export Citation

EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Cited By

J Nephropharmacol. 2023;12(2): e10606.
doi: 10.34172/npj.2023.10606

Scopus ID: 85161967933
  Abstract View: 889
  PDF Download: 442

News and Views

Promising role of sodium-glucose cotransporter-2 inhibitors in IgA nephropathy

Samaneh Zandifar 1 ORCID logo, Shokouh Shayanpour 2* ORCID logo

1 Independent Researcher, Isfahan, Iran
2 Chronic Renal Failure Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
*Corresponding Author: Shokouh Shayanpour, Email: shayanpour-sh@ajums.ac.ir, , Email: dr.shayanpour@yahoo.com

Implication for health policy/practice/research/medical education:

Sodium-glucose cotransporter-2 inhibitors is a promising treatment option for patients with diabetes-associated renal dysfunction.

Please cite this paper as: Zandifar S, Shayanpour S. Promising role of sodium-glucose cotransporter-2 inhibitors in IgA nephropathy. J Nephropharmacol. 2023;10(2):e10606. DOI: 10.34172/npj.2023.10606.

First Name
Last Name
Email Address
Comments
Security code


Abstract View: 890

Your browser does not support the canvas element.

PDF Download: 442

Your browser does not support the canvas element.